(Q30746912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

A linearization approach for the model-based analysis of combined aggregate and individual patient data (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Patanjali Ravva

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Mats O Karlsson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

English

0 references

publication date

2 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

published in

Statistics in Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1460-1476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

Model-based drug development

7 March 2020

cites work

1 reference

Model-based meta-analysis for comparative efficacy and safety: application in drug development and beyond

21 January 2018

1 reference

Meta-analysis of the literature or of individual patient data: is there a difference?

21 January 2018

1 reference

Meta-analysis of continuous outcome data from individual patients.

21 January 2018

1 reference

Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes

21 January 2018

1 reference

Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods

21 January 2018

1 reference

Meta-analysis of ordinal outcomes using individual patient data.

21 January 2018

1 reference

Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.

21 January 2018

1 reference

Multilevel modelling of medical data

21 January 2018

1 reference

A multilevel model framework for meta-analysis of clinical trials with binary outcomes.

21 January 2018

1 reference

Ecological bias, confounding, and effect modification

21 January 2018

1 reference

Improving ecological inference using individual-level data

21 January 2018

1 reference

Heterogeneity and Aggregation

21 January 2018

1 reference

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

21 January 2018

1 reference

Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.

21 January 2018

1 reference

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes

21 January 2018

1 reference

Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes.

21 January 2018

1 reference

Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea

21 January 2018

1 reference

Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes

21 January 2018

1 reference

Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes.

21 January 2018

1 reference

Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response

21 January 2018

1 reference

Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus

21 January 2018

1 reference

Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.

21 January 2018

1 reference

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea

21 January 2018

1 reference

Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes

21 January 2018

1 reference

Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*.

21 January 2018

1 reference

Efficacy and tolerability of vildagliptin in patients with type 2 diabetes inadequately controlled with metformin monotherapy

21 January 2018

1 reference

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone

21 January 2018

1 reference

Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes

21 January 2018

1 reference

Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

Health-exposure modeling and the ecological fallacy.

21 January 2018

1 reference

Covariate heterogeneity in meta-analysis: criteria for deciding between meta-regression and individual patient data

21 January 2018

1 reference

How should meta-regression analyses be undertaken and interpreted?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SIM.6045

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24488864%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference